Suscribirse

A randomized trial of a computer-based intervention to reduce utilization of redundant laboratory tests - 08/09/11

Doi : 10.1016/S0002-9343(98)00410-0 
David W Bates, MD, MSc a, b, , Gilad J Kuperman, MD, PhD a, Eve Rittenberg, MA b, Jonathan M Teich, MD, PhD a, Julie Fiskio a, Nell Ma’luf b, Andrew Onderdonk, PhD c, Donald Wybenga, MD c, James Winkelman, MD c, Troyen A Brennan, MD b, d, Anthony L Komaroff, MD a, b, Milenko Tanasijevic, MD c
a Center for Applied Medical Information Systems (DWB, GJK, JMT, JF, ALK), Boston, Massachusetts., USA 
b Division of General Medicine, Department of Medicine (DWB, ER, NM, TAB, ALK), Boston, Massachusetts., USA 
c Clinical Laboratories and Department of Pathology (AO, DW, JW, MT), Brigham and Women’s Hospital, Boston, Massachusetts., USA 
d Department of Health Policy and Management, Harvard School of Public Health (TAB), Boston, Massachusetts., USA 

*Requests for reprints should be addressed to David W. Bates, MD, MSc, Division of General Medicine and Primary Care, Brigham and Women’s Hospital, 75 Francis Street, Boston, Massachusetts 02115

Abstract

PURPOSE: To determine the impact of giving physicians computerized reminders about apparently redundant clinical laboratory tests.

SUBJECTS AND METHODS: We performed a prospective randomized controlled trial that included all inpatients at a large teaching hospital during a 15-week period. The intervention consisted of computerized reminders at the time a test was ordered that appeared to be redundant. Main outcome measures were the proportions of clinical laboratory orders that were canceled and the proportion of the tests that were actually performed.

RESULTS: During the study period, there were 939 apparently redundant laboratory tests among the 77,609 study tests that were ordered among the intervention (n = 5,700 patients) and control (n = 5,886 patients) groups. In the intervention group, 69% (300 of 437) of tests were canceled in response to reminders. Of 137 overrides, 41% appeared to be justified based on chart review. In the control group, 51% of ordered redundant tests were performed, whereas in the intervention group only 27% of ordered redundant tests were performed (P <0.001). However, the estimated annual savings in laboratory charges was only $35,000. This occurred because only 44% of redundant tests performed had computer orders, because only half the computer orders were screened for redundancy, and because almost one-third of the reminders were overridden.

CONCLUSIONS: Reminders about orders for apparently redundant laboratory tests were effective when delivered. However, the overall effect was limited because many tests were performed without corresponding computer orders, and many orders were not screened for redundancy.

El texto completo de este artículo está disponible en PDF.

Esquema


 Supported by Grant RO1 HS08927 from the Agency for Health Care Policy and Research.


© 1999  Excerpta Medica Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 106 - N° 2

P. 144-150 - février 1999 Regresar al número
Artículo precedente Artículo precedente
  • A randomized controlled trial of the effect of fluid extract of Echinacea purpurea on the incidence and severity of colds and respiratory infections
  • Wolfram Grimm, Hans-Helge Müller
| Artículo siguiente Artículo siguiente
  • Level of physical activity and the risk of radiographic and symptomatic knee osteoarthritis in the elderly: the Framingham Study
  • Timothy E McAlindon, Peter W.F Wilson, Piran Aliabadi, Barbara Weissman, David T Felson

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.